Status:
WITHDRAWN
Feasibility and Safety of Using Nasal High Flow Oxygen Postoperatively to Reduce Respiratory Complications
Lead Sponsor:
University Hospitals of North Midlands NHS Trust
Conditions:
Cancer of the Esophagus
Eligibility:
All Genders
18+ years
Brief Summary
The use of nasal high flow in patients undergoing oesophagectomy is a novel technique that has not been previously studied. Nasal high flow will be delivered postoperatively to patients undergoing oe...
Detailed Description
Respiratory complications including pneumonia, pleural effusion, adult respiratory distress syndrome and pulmonary embolism will be recorded. The primary endpoint will be the rate of postoperative res...
Eligibility Criteria
Inclusion
- Over 18 years old
- Undergoing Ivor-Lewis (2-stage) oesophagectomy
- Successfully extubated within 4 hours after surgery
Exclusion
- History of bullous emphysematous disease
- Lack of capacity to consent
- Significant air leak during surgery
- Incurable disease found at surgery leading to no surgical resection
- Failure of extubation and spontaneous breathing within 4 hours after surgery
Key Trial Info
Start Date :
October 1 2019
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
March 31 2020
Estimated Enrollment :
Patients enrolled
Trial Details
Trial ID
NCT04272268
Start Date
October 1 2019
End Date
March 31 2020
Last Update
April 15 2024
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Robert James Bowler
Stoke-on-Trent, Staffordshire, United Kingdom, ST44JJ